Abstract
In the past, HIV was often detected late in the disease course and management consisted primarily of treating associated opportunistic infections. With better surveillance and the development of more effective antiretroviral medications with fewer toxic side effects, HIV is in many ways now viewed as a chronic illness requiring long-term management. Despite these advances, an estimated 21% of HIV-infected individuals are unaware of their infection.1 More attention has therefore been focused on identifying these individuals through screening and targeted testing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
CDC. HIV prevalence estimates–United States, 2006. MMWR. 2008;57[No. 39]:1073–1076.
Desquilbet L, Jacobson L, Fried LP, et al. Multicenter AIDS cohort study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol Biol Sci Med Sci. 2007;62A:1279-86.
CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR. 2005;54[No. RR-09]: 1–17.
Horberg MA, Hurley LB, Klein DB, et al. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg. 2006;141:1238-45.
Morrison CA, Wyatt WM, Carrick MM. Effects of human immunodeficiency virus status on trauma outcomes: a review of the national trauma database. Surg Infect. 2010;11:41-7.
Habermann B, Eberhardt C, Kurth AA. Total joint replacements in HIV positive patients. J Infect. 2008;57:41-6.
Louis J, Landon MB, Gersnoviez RJ, et al. Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol. 2007;110:385-90.
Blumberg EA, Stock P. The AST Infectious Diseases Community of Practice. Solid organ transplantation in the HIV-infected patient. Am J Transplant. 2009;9:S131-S135.
CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55[No. RR-14]:1–17.
Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of Âantiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1–161. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 5/7/10.
Perinatal HIV Guidelines Working Group. Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected. Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010; pp 1–90. Available at http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed 3/3/10.
Kuritzkes DR, Parenti D, Ward DJ, et al. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. AIDS. 1998;12:65-74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brooks, R.B. (2011). HIV. In: Cohn, S. (eds) Perioperative Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-498-2_25
Download citation
DOI: https://doi.org/10.1007/978-0-85729-498-2_25
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-497-5
Online ISBN: 978-0-85729-498-2
eBook Packages: MedicineMedicine (R0)